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Induction of specific neuronal fates is restricted in time and space in the developing
CNS through integration of extrinsic morphogen signals and intrinsic determinants.
Morphogens impose regional characteristics on neural progenitors and establish distinct
progenitor domains. Such domains are defined by unique expression patterns of fate
determining transcription factors. These processes of neuronal fate specification can
be recapitulated in vitro using pluripotent stem cells. In this review, we focus on the
generation of dopamine neurons and motor neurons, which are induced at ventral
positions of the neural tube through Sonic hedgehog (Shh) signaling, and defined at
anteroposterior positions by fibroblast growth factor (Fgf) 8, Wnt1, and retinoic acid (RA).
In vitro utilization of these morphogenic signals typically results in the generation of
multiple neuronal cell types, which are defined at the intersection of these signals. If
the purpose of in vitro neurogenesis is to generate one cell type only, further lineage
restriction can be accomplished by forced expression of specific transcription factors
in a permissive environment. Alternatively, cell-sorting strategies allow for selection
of neuronal progenitors or mature neurons. However, modeling development, disease
and prospective therapies in a dish could benefit from structured heterogeneity, where
desired neurons are appropriately synaptically connected and thus better reflect the
three-dimensional structure of that region. By modulating the extrinsic environment
to direct sequential generation of neural progenitors within a domain, followed by
self-organization and synaptic establishment, a reductionist model of that brain region
could be created. Here we review recent advances in neuronal fate induction in vitro,
with a focus on the interplay between cell intrinsic and extrinsic factors, and discuss the
implications for studying development and disease in a dish.
Keywords: stem cells, in vitro neuronal networks, dopamine neuron, motor neuron, Parkinson disease,
amyotrophic lateral sclerosis
INTRODUCTION
Induction of specific neuronal fates is restricted temporally
and spatially in the developing central nervous system (CNS)
through the coordinated integration of extrinsic morphogen
signals and intrinsic determinants. The morphogens impose
regional characteristics on neural progenitors at early develop-
mental stages in a concentration-dependent fashion and establish
distinct progenitor domains. Such domains are defined by unique
expression patterns of transcription factors, which determine
neuronal fate. These processes of neuronal fate specification can
be recapitulated in vitro using pluripotent stem cells derived
from embryonic stem cells (ESCs) or induced pluripotents stem
cells (iPSCs).
DOPAMINE AND OCULOMOTOR NEURON DEVELOPMENT
The developing ventral mesencephalon contains dopamine neu-
rons of the substantia nigra pars compacta (SNc, A9 dopamine
neurons) and the ventral tegmental area (VTA, A10 dopamine
neurons), which are distinct in morphology, expression of G-
protein-gated inwardly rectifying K+ channel 2 (Girk2) (Karschin
et al., 1996), calbindin (Yamada et al., 1990; Liang et al., 1996; Liu
et al., 1999), and Raldh1 (McCaffery and Drager, 1994; Chung
et al., 2005; Jacobs et al., 2007) (Figure 1A). Moreover, they
differ in their axonal projections and vulnerability to degener-
ation in Parkinson disease (Yamada et al., 1990; Damier et al.,
1999a). Parkinson disease is characterized by cellular loss of
SNc dopamine neurons that project to the striatum. Dopamine
neurons of the VTA also degenerate, but to a lesser extent
(Damier et al., 1999b). The developing midbrain also contains
oculomotor neurons, which are general somatic efferents, con-
nected with extraocular muscles and coordinating eye movement
(Figure 1A). Oculomotor neurons are molecularly distinct from
other somatic motor neurons (Hedlund et al., 2010) and require
the transcription factor Phox2a (Pattyn et al., 1997), while lacking
the transcription factor Hb9. Furthermore, oculomotor neurons
are resistant to degeneration in the lethal diseases amyotrophic
lateral sclerosis (ALS) and spinal muscular atrophy (SMA) (Gizzi
et al., 1992; Kubota et al., 2000; Nimchinsky et al., 2000), which
are characterized by the loss of somatic motor neurons that
innervate muscles in arms, legs, trunk, and face.
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FIGURE 1 | Topographical organization of the midbrain and spinal cord
in the embryo. (A) Cross section of the midbrain, at E15.5, displaying
oculomotor motor neurons (OM), innervating the ocular muscles, neurons of
the red nucleus (RN) and dopamine neurons, subdivided into substantia nigra
(A9) and ventral tegmental area (A10). (B) Motor neuron division in motor
columns along the spinal cord at E13.5. Lateral motor column (LMC) motor
neurons, innervating limb muscles, are present in brachial and lumbar
segments. The preganglionic column (PGC), containing visceral motor
neurons and the hypaxial motor column (HMC), innervating the abdominal
walls, are present at thoracic levels. Medial motor column (MMC) motor
neurons, innervating proximal muscles, are present all along the spinal cord.
D, dorsal; V, ventral.
FIGURE 2 | Morphogen signaling during neural tube development.
During embryogenesis, neurons present in the midbrain (MB), including
dopamine and oculomotor neurons are born at the intersection of the
signaling molecules Shh, Wnt1, and Fgf8. Spinal motor neurons (MNs) are
patterned by Retinoic Acid (RA) and Shh. Sagital and coronal views at the
midbrain and spinal cord levels of the mouse embryo showing the
expression patterns of these morphogens. FP, floor plate; IsO, isthmic
organizer; MB, midbrain; NC, notochord; OV, otic vesicle; RP, roof plate; SC,
spinal cord; ZLI, zona limitans intermedia; r1, rhombomer 1; r2, rhombomer
2; D, dorsal; V, ventral. Adapted from Aguila et al., 2012.
Dopamine neurons and oculomotor neurons are induced in
the ventral neural tube of the midbrain through the actions of
the morphogens Sonic hedgehog (Shh), fibroblast growth fac-
tor 8 (Fgf8), Wnt1 and retinoic acid (RA) (Figure 2). Midbrain
dopamine neurons are generated from neuroepithelial cells of
the floor plate that have a non-neurogenic character (Andersson
et al., 2006; Ono et al., 2007). The floor plate is a specialized
glial structure located in the most ventral midline of the neural
tube from the midbrain to the tail region (Strahle et al., 2004).
It controls neuronal subtype specification along the dorsoventral
(D-V) axis through the secretion of Shh (Jessell, 2000). The capac-
ity of the floor plate to give rise to neurons is restricted along
the rostrocaudal axis of the brain, where floor plate cells located
caudally to the midbrain do not normally give rise to neurons
(Ono et al., 2007).
The isthmic organizer forms a boundary between the mid-
brain and hindbrain and controls patterning of the midbrain
and the anterior hindbrain. It is essential for the specification
and normal development of dopamine neurons and serotonin
neurons (Brodski et al., 2003). Several signaling factors, includ-
ing Shh, Fgf8, Fgf17, Fgf18, and Wnt1, are expressed by and
around the isthmic organizer and are involved in this process
(Figure 2). The combination of Shh and Fgf8 is necessary for the
induction of dopamine neurons in the rostral forebrain and the
lateral midbrain (Wang et al., 1995; Ye et al., 1998). However,
Shh is no longer required after embryonic (E) day E10.5 in the
mouse. At this developmental stage, Foxa2, a forkhead tran-
scription factor, induced by Shh, is essential for the generation
of midbrain dopamine neurons (Ferri et al., 2007). ChIP-seq
analysis recently showed that Foxa2 positively regulated determi-
nants of dopamine neurons, including the transcription factors
Lmx1a, Lmx1b, Msx1, and Ferd31, while repressing ventrolat-
eral genes in midbrain dopamine progenitors, including Helt,
Tle4, Otx1, Sox1, and Tal2. Foxa2 also repressed the expression
of Gli1, Gli2, and Gli3, which are the intracellular transducers
of Shh signaling (Mavromatakis et al., 2011). Foxa2 has pre-
viously been shown to regulate the expression of the orphan
transcription factor NR4A2 (Nurr1) (Ferri et al., 2007), which
is required for the induction of a number of genes that confer a
dopamine neuron transmitter phenotype, including TH, VMAT2,
DAT, AADC, and c-ret (Wallen et al., 1999). In addition, Foxa2
appears to play a role in regulating axon trajectories around the
midline through targets including Slit2 and 3 (Metzakopian et al.,
2012). The transcription factors Lmx1a and Lmx1b are impor-
tant for the specification of dopamine neurons (Smidt et al.,
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2000; Andersson et al., 2006). Importantly, dopamine progenitors
in the developing midbrain can be subdivided into molecularly
distinct medial and lateral domains and these show differen-
tial sensitivity to the loss of Lmx1a and Lmx1b. Here, Lmx1a
converts non-neuronal floor plate cells into medial dopamine
progenitors (Andersson et al., 2006; Ono et al., 2007). However,
Lmx1a is not absolutely required for the generation of these
neurons, since the deficiency in dopamine neurogenesis in the
Lmx1a knockout mouse recovers over time (Deng et al., 2011).
Lmx1b is required for generating lateral dopamine progenitors,
that in fact do not appear to originate from the floor plate, and
which are selectively ablated in Lmx1b mutants (Deng et al.,
2011). Oculomotor neurons are generated immediately lateral to
the dopamine progenitor domain from cells that express Lmx1b,
Phox2a, Sim1, and Nkx6.1. The sequential generation of ocu-
lomotor neurons and red nucleus neurons seems controlled by
Lmx1b, which is more broadly expressed than Lmx1a in the early
developing midbrain, through the activation of Phox2a (Deng
et al., 2011). Phox2a, in turn, is required and sufficient to pro-
mote oculomotor neuron fate (Pattyn et al., 1997; Hasan et al.,
2010) and to suppress the generation of red nucleus neurons
at early developmental stages. Sim1, which is co-expressed with
Phox2a in this progenitor pool, likely contributes to the specifica-
tion of red nucleus neurons, but its activity appears suppressed
by Phox2a (Deng et al., 2011). Phox2b is expressed in oculo-
motor neurons and ectopic expression of Phox2b is sufficient to
induce Phox2a+ cranial motor neurons in the spinal cord (Pattyn
et al., 1997; Dubreuil et al., 2000). Furthermore, the migration
of newly born oculomotor neurons appears regulated by the Shh-
inducible homedomain trancription factor Nkx6.1 (Prakash et al.,
2009).
During early development, starting at E9, Fgf8 is expressed by
the isthmic organizer (Heikinheimo et al., 1994) and can mimic
the isthmic activity (Crossley et al., 1996; Lee et al., 1997). Fgf8
appears to maintain normal development of the midbrain and
hindbrain by regulating transcription factors such as engrailed-1
(En1), En2, and Pax5 (Liu et al., 1999). Furthermore, Fgf8 appears
to regulate anteroposterior patterning of dopamine neurons in
a cell-autonomous manner and is neccessary for maturation of
dopamine neurons (Lahti et al., 2012). Fgf8 also directs the rostral
growth of axons from midbrain dopamine neurons by inducing
the repulsion factor semaphorin 3F (Yamauchi et al., 2009). The
migration and process orientation of VTA and SNc dopamine
neurons can also be regulated through the interaction of CXCR4
in Nurr1+ dopamine progenitors and neurons and Cxcl12 in
meningeal cells surrounding the ventral midbrain (Yang et al.,
2013).
Wnt1 expression precedes Fgf8, starting at E8.0 and is required
for early midbrain development. During early somite stages,
Wnt1 is broadly expressed in the presumptive mesencephalon,
but following neural tube closure, the expression gradually
becomes refined to a narrow band of cells located immediately
rostral to the isthmus and the dorsal midline of the CNS (Parr
et al., 1993) (Figure 2). While Wnt1 does not have isthmic-like
activity, it is essential, and deletion results in loss of midbrain
and cerebellar structures by E10 and a reduction in the number
of midbrain dopamine neurons (McMahon and Bradley, 1990;
Thomas and Capecchi, 1990; McMahon et al., 1992; Panhuysen
et al., 2004). Wnt1 appears necessary for the development of
midbrain dopamine neurons since Fgf8 and Shh fail to induce
expression of tyrosine hydroxylase (TH) (the rate limiting enzyme
in dopamine synthesis) and the homedomain transcription fac-
tor Pitx3 (which is normally selectively expressed in midbrain
dopamine neurons) in the Wnt1 knockout mouse (Prakash et al.,
2006). Wnt1 and Wnt5 double knockout mice showed a greater
loss of dopamine progenitors and neurons than single mutants,
indicating that Wnt1 and Wnt5a cooperate to promote midbrain
dopamine neurogenesis (Andersson et al., 2013). Ectopic expres-
sion of Wnt1 in the posterior hindbrain can induce midbrain
dopamine neurons through the activation of the transcription
factor Otx2 and the repression of Gbx2 and Nkx2.2 and induction
of dopaminemarkers (Prakash et al., 2006). If ectopicWnt signal-
ing is combined with restored Lmx1b levels, midbrain dopamine
neurons can be generated at even more posterior levels of the
hindbrain, but not in the spinal cord (Joksimovic et al., 2012).
Interestingly, Otx2 appears to determine the anterior identity that
confers neurogenic potential of floor plate cells. Consequently,
ectopic expression of Otx2 in the ventral hindbrain induces mid-
brain dopamine neurons, partly by inducing Lmx1a from floor
plate cells, which normally do not give rise to neurons (Ono et al.,
2007).
While Wnt1 expression is largely unaffected by Lmx1a loss-of-
function, Lmx1b is a crucial regulator ofWnt1 expression in mid-
brain dopamine progenitors at later developmental stages (Deng
et al., 2011). In addition to the role of canonical Wnt signaling in
early specification, Wnt1 and Wnt3a increase neurogenesis and
regulate the proliferation of Nurr1-positive midbrain dopamine
precursor cells (Castelo-Branco et al., 2003). Likewise, disrup-
tion of canonical Wnt signaling leads to neurogenesis defects and
perturbs the migration and segregation of midbrain dopamine
neurons (Tang et al., 2009). Wnt2 is also involved in midbrain
dopamine neurogenesis through activation of the canonical path-
way (Sousa et al., 2010). Wnt5a increases the number of midbrain
dopamine neurons by promoting the acquisition of a fully mature
dopaminergic phenotype through upregulation of Pitx3 expres-
sion (Castelo-Branco et al., 2003). Wnt5a is also thought to
control morphogenesis, dopamine progenitor cell division, cell
cycle exit (Andersson et al., 2008) and to be involved in dopamine
axon growth and targeting (Blakely et al., 2011).
RA also seems to play a role in midbrain dopamine neuron
differentiation. Retinal dehydrogenase 1 (Raldh1), which converts
retinaldehyde into RA, is expressed in the vental midbrain already
at E9.5 (Wallen et al., 1999). Raldh1 (and thus the RA level) is
transcriptionally regulated in the midbrain by Pitx3 (Chung et al.,
2005; Jacobs et al., 2007). Deficiency in Pitx3 results in the selec-
tive loss of substantia nigra compacta dopamine neurons (Hwang
et al., 2003). Maternal supplementation of RA could partially res-
cue SNc dopamine neuron degeneration in the Pitx3 knockout
mice (Jacobs et al., 2007). Pitx3 appears to regulate genes in both
an RA-dependent and an RA-independent manner, which could
explain the partial, but not complete, rescue of SNc dopamine
neurons after RA supplementation in Pitx3 knockout mice. Here,
the Pitx3 downstream targets Vmat2, Dat, Raldh1, En1, En2, and
Cck were unaffected by RA treatment (Jacobs et al., 2011).
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Other morphogens and growth factors are important for sur-
vival and maturation of midbrain dopamine neurons. Members
of the transforming growth factors beta (TGFβ) superfamily,
bone morphogenetic proteins (BMPs) 2, 6, and 7 are expressed
in the developing ventral midbrain and promote the survival
of dopamine neurons in the rat (Jordan et al., 1997; Chou
et al., 2008a,b). Furthermore, TGFβ2-3, activin and glial cell line-
derived neurotrophic factor (GDNF) are neurotrophic factors for
dopmine neurons (Lin et al., 1993; Poulsen et al., 1994; Krieglstein
et al., 1995a,b; Farkas et al., 2003; Roussa et al., 2006). GDNF
appears to act as a target-derived neurotrophic factor through
its high expression in striatal neurons that are innervated by
SNc dopamine neurons (Hwang et al., 2003; Oo et al., 2005). In
addition, GDNF is transiently expressed in the midbrain during
dopamine neuron specification. Here, GDNF induces Pitx3 via
NF-κB-mediated signaling. Pitx3 is in turn required for activating
the expression of brain-derived neurotrophic factor (BDNF) in a
subpopulation of SNc dopamine neurons during embryogenesis.
The loss of BDNF expression correlates with the increased apop-
totic cell death of SNc dopamine neurons in the Pitx3 knockout
mouse (Peng et al., 2011).
SPINAL MOTOR NEURON DEVELOPMENT
Motor neurons are the main regulators of movement, they extend
axons that reach the periphery from the CNS and innervate
skeletal and smooth muscles, forming neuromuscular junctions
(NMJs). In the fatal neurodegenerative diseases amyotrophic lat-
eral sclerosis (ALS) and spinal muscular atrophy (SMA), motor
neurons degenerate, leading to progressive paralysis and respira-
tory failure. Motor neurons are found at different levels of the
CNS, in the cortex, midbrain, hindbrain and spinal cord. Motor
neurons present in the spinal cord can be divided into three sub-
groups: alpha (α), beta (β), and gamma (γ), depending on the
type of muscle fiber they innervate. Muscle fibers can be intra
or extrafusal according to their role in motor control. Extrafusal
fibers are innervated by α motor neurons and generate contrac-
tion, while intrafusal fibers are innervated by γ motor neurons
and serve in fine motor control and proprioception. βmotor neu-
rons are less well-described, but are known to innervate both fiber
types. α motor neurons are the most abundant subtype present
in the spinal cord and are known to display a larger size and
more extensive connectivity within the spinal cord compared to
γ motor neurons. In fact, α and γ motor neurons differ also in
their pre-synaptic inputs and post-synaptic targets.
α motor neurons can be further subdivided into fast-twitch
fatigable (FF), fast-twitch fatigue-resistant (FR), and slow-twitch
fatigue-resistant (S), depending on the contractile properties of
the muscle fibers they innervate (Burke et al., 1973). Importantly,
these motor neuron groups show differential vulnerability to
degeneration in ALS (Kawamura et al., 1981; Frey et al., 2000).
Motor neurons differ in cell size based on their functional prop-
erties and the fiber type they innervate (Henneman et al., 1965;
Kernell et al., 1999). For instance, themotor unit formation (mus-
cle fibers innervated by the samemotor neuron) has a hierarchical
composition, and the size of the recruited motor neurons is cor-
related to the muscle unit force. For this reason, FF and FR motor
neurons, that are characterized by higher force requirement, are
larger in size than S motor neurons (Kernell et al., 1999). Slow
and fast twitch motor neurons can be distinguished by a set of
markers, at least during adulthood. For example, the expression
of the synaptic vesicle protein SV2A is described to be restricted
to S motor neurons (Chakkalakal et al., 2010). Moreover, oxida-
tive enzymes showed greater cytoplasmic activity in smaller sized
motor neurons, with higher levels of succinate dehydrogenase
(SDH) being found in S motor neurons (Kernell et al., 1999). In
contrast, fast twitch motor neurons presented higher levels of cal-
citonin gene-related peptide (CGRP). It has been suggested that
CGRP has a role in connectivity maintenance, and thus is largely
expressed in motor neurons presenting many terminal branches
(Piehl et al., 1993; Kernell et al., 1999).
During development, motor neurons are grouped into
columns and pools, acquiring a distinct topographic identity
(Figure 1B). Motor neurons show different identities depending
on the columnar group they belong to, and each column has a
defined position on the rostro-caudal axis of the spinal cord. Four
different columns, which innervate specific peripheral targets, can
be found in the spinal cord. Lateral motor column (LMC) motor
neurons are present at limb levels of the spinal cord and inner-
vate limb muscles. The medial motor column motor neurons
(MMC) innervating dorsal axial musculature are present at all
levels of the spinal cord (Prasad and Hollyday, 1991; Gutman
et al., 1993). The hypaxial motor column (HMC), also found
at thoracic levels, is innervating intercostal and abdominal wall
musculature. The preganglionic column (PGC) is composed of
visceral motor neurons found at thoracic levels and innervating
sympathetic ganglia (Figure 1B). LMCmotor neurons are further
divided into lateral motor neurons projecting dorsally to inner-
vate extensor muscles, and medial motor neurons, projecting
ventrally to innervate flexor muscles (Landmesser, 1978a; Tosney
and Landmesser, 1985). Importantly, the segregation of motor
neurons into motor columns correlates with the expression of
distinct LIM-homeodomain transcription factors (Tsuchida et al.,
1994) and Hox genes (Dasen et al., 2003, 2005, 2008).
Furthermore, motor neurons belonging to a given column
are organized into pools. A motor pool consists of motor neu-
rons that innervate a single muscle. Motor neurons display
different positions inside the LMC column and innervate dis-
tinct target muscles depending on their topographic distribu-
tion (Landmesser, 1978b; Hollyday and Jacobson, 1990). In this
respect, the LIM homeodomain protein Lhx1 directs dorsal LMC
projections in the limbs, through the regulation of the EphA4
guidance receptor (Eberhart et al., 2002; Kania and Jessell, 2003).
Moreover, Hox genes seem to be crucial both in LMCmotor neu-
ron pool identity determination and in the high precision of axon
muscle targeting (Landmesser, 2001; Dasen et al., 2003).
Spinal motor neurons are generated through a specific gradi-
ent of extrinsic signals found in the embryo neural tube, acting
along the dorso-ventral and rostro-caudal axis. Cells forming the
ectoderm cell layer acquire an initial rostro-caudal and dorso-
ventral identity mainly through the combined action of Shh and
RA. Shh, as mentioned in section Dopamine and Oculomotor
Neuron Development, is secreted from the notochord and the
floor plate of the neural tube and is needed for ventralization
(Ericson et al., 1996). Caudalization is regulated by a gradient of
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RA, produced initially by the presomitic mesoderm and somites
(Maden, 2007) and is later on (around E11–12) found in the neu-
ral tube, all along the spinal cord (Horton and Maden, 1995)
(Figure 2). BMP signaling is known to induce a dorsal identity,
however, in combination with Shh, it was found to exert roles also
ventrally. For instance, knock down of BMP in zebrafish embryos
altered the localization of ventral neuronal subtypes (Barth et al.,
1999; Nguyen et al., 2000). Neuronal progenitor response in vitro
to Shh was found to be dependent on the BMP concentration
(Liem et al., 2000). The patterning induced by Shh signaling activ-
ity promotes the expression of transcription factors characteristic
of motor neuron progenitors, including the homeodomain tran-
scription factors Pax6, Nkx6.1, and Nkx6.2 (Vallstedt et al., 2001)
and the basic helix-loop-helix (bHLH) transcription factors Olig1
and Olig2 (Novitch et al., 2001; Zhou and Anderson, 2002).
Moreover, during motor neuron generation (E9.5) cells start to
express a defined pattern of transcription factors, including the
homeobox gene Hb9 (Arber et al., 1999) and the LIM home-
odomain genes Isl1 and Lhx3 (Ericson et al., 1992; Sharma et al.,
1998). The expression of this group of transcription factors is cru-
cial for motor neurons to acquire both capabilities of projecting
axons to connect to muscles and releasing the neurotransmitter
acetylcholine.
Two main transcription factors, Lhx3 and FoxP1, are used to
discriminate between MMC and LMC motor neurons, in vivo
and in vitro after induction of motor neurons from pluripotent
stem cells (Figures 3A–C). Lhx3 is transiently expressed in all
motor neuron progenitors, but is restricted to MMC motor neu-
rons during later stages (Sharma et al., 1998). The maintained
expression of Lhx3 renders motor neurons refractory to Hox
gene patterning and the consequent segmentation into colum-
nar identities (Tsuchida et al., 1994; Sharma et al., 2000; Dasen
et al., 2003, 2005, 2008). Lhx3 expression and MMC identity is
induced by the combined activity of Wnt4, Wnt5a, and Wnt5b,
which are expressed in and around the floor plate. Increased lev-
els of Wnt4/5 generated a majority of MMC motor neurons at
the expense of LMC and HMC motor neurons, while depletion
of Wnt4/5 reduced the number of MMC motor neurons (Agalliu
et al., 2009). Forced expression of Lhx3 can reroute motor neu-
rons and guide axons to proximal muscles (Sharma et al., 2000).
FoxP1 is expressed in LMC motor neurons, and appears to inter-
act with Hox proteins, as an accessory factor, to specify motor
columnar identity, in a dose-dependent manner. Knock down of
FoxP1 abolished LMC and MMC differentiation and reverted the
spinal motor system to an ancestral state, lacking LCM motor
neurons (Dasen et al., 2008), thus mimicing early aquatic verte-
brate motor systems that contained only MMC and HMC motor
columns (Fetcho and Reich, 1992). Loss of FoxP1 severely affected
motor neuron connectivity patterns with limb axons appearing
to select their projections and muscle targets at random (Dasen
et al., 2008).
A second patterning system acting on the anteroposterior axis
is triggered by a gradient of Fgf8, Gdf11, and RA, and induces
the diversification of the already formed motor neurons (Liu
et al., 2001; Dasen et al., 2003; Mazzoni et al., 2013). Gdf11
is a member of the TGFβ family, produced by the notochord
and active at posterior levels. Fgf levels are also higher posterior,
while RA exerts its action at anterior positions. This pattern-
ing induces the expression of Hox genes (Liu et al., 2001; Dasen
et al., 2003, 2005, 2008), which are known to differ depend-
ing on the segmental level of the spinal cord (Carpenter, 2002).
Specifically, lower levels of Fgf (from the presomitic mesoderm)
induces the expression of Hox4–Hox8 genes at the cervical level
of the spinal cord, while progressively higher levels of Fgf8 pro-
vokes Hox8–Hox9 and Hox10–Hox13 expression at thoracic and
lumbar levels, respectively (Liu et al., 2001; Bel-Vialar et al., 2002;
Dasen et al., 2003). These distinct Hox genes regulate motor col-
umn and pool identities. For instance, Hox6 determines cervical
LMC motor neuron identity, while Hox10 specifies lumbar LMC
motor neurons and Hox9 is needed for PGC neuron differen-
tiation (Dasen et al., 2003; Shah et al., 2004; Wu et al., 2008).
Misexpression of Hox genes can induce a motor column iden-
tity switch, with e.g., Hoxc9 expression at cervical levels switching
the LMC to a PGC identity (Dasen et al., 2003). However, HMC
and MMC columns are considered Hox-independent, due to
their expression of Lhx3, which is a suppressor of FoxP1 and
Hox genes in determining LMC/PGC fate. (Dasen et al., 2003,
2008; Rousso et al., 2008; Agalliu et al., 2009). Interestingly,
the Wnt4/5-Lhx3 pathway seems to repress the Fgf-Hox path-
way and vice versa (Agalliu et al., 2009). Hox gene regulation is
FIGURE 3 | Lateral and medial motor column motor neurons are
distinguished by FoxP1 and Lhx3 expression. Schematic drawing of lateral
(LMC) and medial (MMC) motor column motor neurons innervating distal and
proximal muscles, respectively (A). Differentiation of Hb9-GFP mESCs into
spinal motor neurons (MNs) using RA and SAG generates FoxP1+ LMC MNs
(B) and Lhx3+ MMC MNs (C). The arrow heads in panels (B) and (C) indicate
motor neurons co-labeled with Hb9-eGFP and FoxP1 (in B) or Hb9-eGFP and
Lhx3 (in C).
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highly complex, exemplified by that cervical LMC motor neu-
rons express 11 different Hox genes (Hoxa3, a4, a5, a6, and
a7; Hoxb7 and b8; and Hoxc4, c5, c6, and c8), some with dis-
tinct and others with co-segregated anterior-posterior expression
domains within the motor column. As mentioned above, Hox
genes play a fundamental role in LMC and PGC column differen-
tiation, and exert their functions in combination with the cofactor
FoxP1. PGC motor neurons show a Hox gene-dependent, lower
level of FoxP1 than LMC motor neurons (Dasen et al., 2008).
Phylogenetically, it seems that some of the more newly gener-
ated HMCneurons, which are devoid of Lhx3, became sensitive to
Hox patterning, diverting from anHMC identity and turning into
PGC and LMC motor neurons. Hox9 influence drives these cells
to a PGC fate, with a consequent loss of Hb9 and acquisition of
low levels of FoxP1. HMC motor neurons, instead, are devoid of
FoxP1 and express Hb9. LMCmotor neurons, patterned by Hox6
(cervical) and Hox10 (lumbar) activity, can express high levels of
FoxP1 without Hb9 repression (Dasen et al., 2008). In addition, as
previously explained, MMC and HMC motor neurons are speci-
fied by the LIM-homeodomain factor Lhx3 (Sharma et al., 1998),
while FoxP1 expression is repressed here (Dasen et al., 2003)
(Figure 3). In addition to controlling motor pool identities, Hox
genes regulate motor neuron axon guidance and muscles-nerve
connections. However, target path finding depends on extrinsic
signals (trophic factors) provided by the mesoderm and mus-
cles, which induce expression of the ETS transcription factors
Pea3 and Er81 (Lin et al., 1998; Arber et al., 2000; Haase et al.,
2002). Interestingly, these transcription factors are not present in
all motor neuron pools, and their expression was shown to further
induce pool organization after motor neurons have reached their
target organs, both in terms of muscle specific innervation and
motor-sensory connectivity and coordination (Livet et al., 2002).
UTILIZING EMBRYONIC STEM CELLS TO MODEL
DEVELOPMENT AND DISEASE
Pluripotent stem cells allow unlimited expansion and derivation
of any cell type and thus represent an excellent source of in vitro
generated neurons. The processes of neuronal fate specification
can be recapitulated in vitro using pluripotent stem cells derived
from ESCs (Evans and Kaufman, 1981; Martin, 1981) or iPSCs
(Takahashi and Yamanaka, 2006). As in the embryo, Shh and RA
specify motor neuron fate from pluripotent stem cells (Wichterle
et al., 2002; Hu and Zhang, 2009). Dopamine neurons (Lee et al.,
2000; Kriks et al., 2011) and oculomotor neurons can be gener-
ated by a combination of Shh, Fgf8, and Wnt (Figures 4A–C).
iPSCs from patients with e.g., Parkinson disease or motor neuron
diseases, including ALS and SMA (Demos et al., 2008; Park et al.,
2008; Corti et al., 2012; Sanchez-Danes et al., 2012; Alami et al.,
2014), are vital tools to study presymptomatic and symptomatic
disease events in a dish. In vitro utilization of morphogens for the
derivation of particular neurons typically results in the generation
of multiple cell types, which are normally defined at the inter-
section of these signals. Thus, the desired neuronal lineage will
constitute only a fraction of the cells. Further lineage restriction
from stem cells can be accomplished by forced expression of spe-
cific transcription factors in a permissive environment, reviewed
below in the section Forced Expression of Transcription Factors
to Induce Neuronal Lineages. Alternatively, cell-sorting strategies
allow for the selection of neuronal progenitors or mature neurons
of a specific lineage, reviewed in the section Cell Sorting Strategies
Allowing for Selection of Neurons.
FORCED EXPRESSION OF TRANSCRIPTION FACTORS TO
INDUCE NEURONAL LINEAGES
Forced expression of transcription factors that determine specific
neuronal fates in vivo can further induce lineage restriction from
pluripotent stem cells. Generation of one cell type only could
be beneficial for cellular therapies in degenerative diseases, for
in vitro drug screening purposes and to study cell intrinsic mech-
anisms. Toward the goal of developing stem cell based therapies
for Parkinson disease, great efforts have been made to generat-
ing highly enriched dopamine neuron cultures. Forced expression
of transcription factors, including Nurr1 (NR4A2), Lmx1a and
Pitx3, in combination with Shh and Fgf8 signaling, can promote
dopamine neuron differentiation (Figure 5A). Nurr1 over expres-
sion increased the proportion of dopamine neurons from 25 to
80% of all neurons. Specifically, Nurr1 up-regulated a dopamine
neurotransmitter phenotype, with increased expression of TH,
DAT, AADC, and c-ret (Chung et al., 2002; Kim et al., 2002).
Pitx3 did not increase the total number of dopamine neurons, but
FIGURE 4 | Differentiation of mESCs into spinal motor neurons
and midbrain neurons. Spinal motor neurons (MNs) were generated
from Hb9-GFP mESCs using RA and SAG (A). MNs express Islet-1,
have a healthy appearance and extend processes. Exposure of
mESCs to SAG and Fgf8 generates midbrain motor neurons (B) that
express NF200, Islet-1/2 and Phox2A, and grow in clusters and
extend neurites and dopamine neurons (C) that express TH, Nurr1,
and Otx2.
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FIGURE 5 | Modulation of intrinsic determinants can promote
induction of midbrain neurons and spinal motor neurons. (A) Shh
and Fgf8 induce midbrain neuron differentiation from stem cells. Forced
expression of specific transcription factors, in a permissive environment,
can further promote induction of specific neuronal lineages. Here we
specifically summarize effects on mouse embryonic stem cells. For
example, Phox2b can increase the percentage of cranial motor neurons
(MNs) (to 90% of the neurons in the culture). Nurr1 and Lmx1a can
induce dopamine neuron fate (to 80% of the neurons in the culture).
Pitx3 can specifically promote an A9 dopamine (DA) neuron fate
without affecting the total number of dopamine neurons in culture
(25% of the neurons in the culture). (B) RA and Shh can induce motor
neuron differentiation from pluripotent stem cells, with 15–30% of all
cells adopting a motor neuron fate. Over-expression of Olig2 can
increase the proportion of spinal motor neurons, without a preference
for LMC or MMC motor neurons (90% of the neurons in culture).
Forced expression of Phox2b induces a cranial motor neuron fate (90%
of the neurons in culture). (C) mESCs can be directly converted into
spinal motor neurons in the absence of Shh and RA, using forced
expression of Ngn2, Isl1, and Lhx3 (NIL) (>99% of the neurons in
culture), or into cranial motor neuron using Ngn2, Isl1, and Phox2a
(NIP) (>99% of neurons in the culture).
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shifted the fate preferentially into SNc-like dopamine neurons,
defined by Raldh1 expression (Chung et al., 2005) (Figure 5A).
Lmx1a over expression in nestin+ cells could trigger dopamine
neuron differentiation, by inducing Msx1 and Ngn2 expression,
with approximately 80% of neurons showing a correct pheno-
type (Andersson et al., 2006; Friling et al., 2009; Panman et al.,
2011). As Lmx1a is also expressed in the roof plate, and a deter-
minant of dorsal cell fates, a ventral environment was necessary
for induction of a dopamine neuron fate (Andersson et al., 2006).
Cranial and spinal motor neuron fates can be induced by over
expression of Phox2a, Phox2b or Olig2 in neuronal precursors,
in combination with morphogens (Figure 5A). Specifically, cra-
nial motor neuron differentiation was promoted by Phox2b, in
combination of Shh and Fgf8 or Shh and RA, to ∼90% of all neu-
rons (Panman et al., 2011) (Figures 5A,B). If over expression of
Phox2b was instead performed in the presence of BMP7 and Fgf8,
noradrenergic neurons were generated. Phox2a, in the presence of
Shh and Fgf8, favored a cranial motor neuron fate (Mong et al.,
2014), while Olig2 in the presence of Shh and RA, increased the
proportion of spinal motor neurons to ∼90% of all neurons.
It has been reported that spinal motor neurons derived
from mESCs, using RA and a Shh agonist (Hh-Ag1.3 or SAG)
showed electrophysiological properties and transcription factor
expression typical of MMC motor neurons (Wichterle et al.,
2002; Soundararajan et al., 2006). A recent study demonstrated
that the combination of two smoothened (Smo) agonists, SAG
and purmorphamine, could increase the proportion of LMC
motor neurons in culture, compared to Shh. The effects of
SAG and purmorphamine alone were not analyzed (Amoroso
et al., 2013), thus precluding a conclusion as to the individ-
ual or synergistic effects of the agonists. In our hands SAG
yields both LMC and MMC motor neurons, defined by the
presence of Lhx3+ and FoxP1+ (Figures 3B,C). It would be of
major interest to perform large-scale chemical screens to fur-
ther identify compounds that can regulate the above-discussed
intrinsic determinants, which are known to shift neuronal
identities in vitro.
Several studies have focused on using multiple transcription
factors to achieve synergistic promotion of neuronal maturation.
The combination of Ngn2, Islet-1, and Phox2a (NIP) induced
cranial motor neuron fate from mESCs more robustly (>95%
of all neurons) than Phox2a alone. This work demonstrated
that transcription factors can work in synergy to induce desired
neuronal lineages with high efficiency. Ngn2, Islet-1, and Lhx3
(NIL) accelerated mouse and human ESC differentiation into
spinal motor neurons (Hester et al., 2011; Mazzoni et al., 2013).
Importantly, NIL factors could promote spinal motor neuron dif-
ferentiation, even in the absence of RA (Figure 5C). However, the
lack of RA decreased Hox4, Hox5, and Hox6 gene expression,
while increasing rostral neural markers. When NIL forced expres-
sion was combined with RA administration, Hox gene expression
was re-established, confirming the fundamental role of RA in pat-
terning cervical motor neurons. Furthermore, the NIP and NIL
factors appeared to directly program pluripotent stem cells into
neurons, determined by lack of progenitor markers Olig1 and
Olig2 and the presence of the post-mitotic marker Hb9 (Mazzoni
et al., 2013).
Forced expression of transcription factors can also be used to
directly convert fibroblasts into neurons. Specifically, introduc-
tion of Asc1, Brn2, and Myt1l (BAM) into mouse fibroblasts was
shown to induce neuron generation (Vierbuchen et al., 2010).
The BAM factors could directly reprogram human pluripo-
tent stem cells (Pang et al., 2011) and fibroblasts (Pfisterer
et al., 2011) to neurons, but the efficiency of human fibrob-
lasts conversion improved greatly by the addition of the bHLH
transcription factor NeuroD1 (Pang et al., 2011). Direct conver-
sion of fibroblasts into dopamine neurons and motor neurons
requires the addition of lineage specific fate determining fac-
tors. Dopamine neurons could be induced when BAM factors
were combined with Lmx1a and FoxA2 (Pfisterer et al., 2011).
However, the combination of the transcription factors, Ascl1,
Nurr1, and Lmx1a appeared more efficient for direct reprogram-
ming of fibroblasts into dopamine neurons (Caiazzo et al., 2011).
Generated dopamine neurons expressed TH, Raldh1, VMAT2
and showed appropriate electrophysiological properties. Here,
also Parkinson disease patient fibroblasts were reprogrammed
(Caiazzo et al., 2011). The combination of the BAM factors with
transcription factors known to determine motor neuron fate,
including Lhx3, Hb9, Isl1, and Ngn2, converted mouse fibrob-
lasts into motor neurons. Moreover, the addition of NeuroD1
allowed for motor neuron differentiation from human fibroblasts
(Son et al., 2011).
The studies reviewed clearly demonstrate the utility of using
forced expression of transcription factors to direct specific neural
fates in a permissive environment in vitro. The resulting enriched
cultures are beneficial for determining cell intrinsic properties of
distinct neuron groups, drug-screenings, disease-modeling and
for transplantation.
CELL SORTING STRATEGIES TO ENRICH FOR NEURONS
While forced expression of transcription factors can efficiently
drive specific neuronal lineage, commonly the culture still con-
tains a mixture of cells, including pluripotent cells, progenitors
and several neuronal types. For both in vitro and in vivo purposes,
the inclusion of actively dividing cells can cause severe problems.
Remaining proliferating cells can quickly become the major cell
type with long-term culturing of stem cell-derived neuronal cul-
tures (Figure 7). Furthermore, it is unlikely that the proliferating
cells will differentiate into the desired neuronal phenotype(s).
Thus, the culture will be continuously diversified unless the pat-
terning phase is maintained. For transplantation purposes the
inclusion of dividing cells can be detrimental due to the poten-
tial formation of tumors or teratomas (Bjorklund et al., 2002).
Removal of unwanted proliferating cells is relatively straight-
forward using cell sorting strategies such as magnetic activated
cell sorting (MACS) or fluorescent activated cell sorting (FACS).
Mouse embryonic and adult stem cells express stage specific
embryonic antigen-1 (SSEA-1), while human stem cells express
SSEA-3 on their surface (Solter and Knowles, 1978; Capela and
Temple, 2002). Removing proliferating SSEA-1+ cells from stem
cell-derived midbrain neuronal cultures using FACS can avert
tumor formation after transplantation (Hedlund et al., 2007,
2008; Wernig et al., 2008; Ganat et al., 2012). It is vital to empha-
size that even the inclusion of small numbers of pluripotent
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stem cells can be detrimental. Indeed, transplantation of cellu-
lar suspensions containing only a fraction of SSEA-1+ cells (<1%
SSEA-1+ cells) sometimes give rise to tumors (Hedlund et al.,
2008; Ganat et al., 2012).
The inclusion of multiple neuronal lineages could result in the
lack of a functional outcome, aberrant results or assays with a
complicated readout. Therefore, it can be advantageous to enrich
for a neuronal cell type of interest, in addition to removing
unwanted proliferating cells (Figure 7). For example, the acciden-
tal inclusion of serotonergic neurons in transplanted Parkinson
disease patients is considered partly responsible for fetal graft-
induced dyskinesia and L-DOPA induced dyskinesia (Carlsson
et al., 2009; Politis et al., 2010; Bezard et al., 2013). Serotonin
neurons can convert L-DOPA into dopamine and synaptically
release it. However, they lack an appropriate feedback control (no
dopamine transporter), which leads to over-stimulation of post-
synaptic dopamine neurons onto striatal neurons. Indeed, fetal
dopamine neuron grafts in Parkinson patients have been shown
to contain serotonergic neurons (Mendez et al., 2005, 2008; Politis
et al., 2010) and these neurons appeared to hyper innervate the
patient striatum (Politis et al., 2010).
Several strategies have been used to enrich for dopamine pro-
genitors or mature dopamine neurons from fetal tissues and from
stem cell-derived cultures. The initial studies which proved that
primary dopamine neurons could be enriched by FACS, used
either NSP-4 based antibody labeling (di Porzio et al., 1987),
dye injection (Kerr et al., 1994) or transgenic fluorescence based
on TH expression (Sawamoto et al., 2001; Donaldson et al.,
2005). Such enriched dopamine neurons could survive in vivo
after transplantation and induce partial functional recovery in 6-
hydroxydopamine lesioned Parkinsonian rats (Sawamoto et al.,
2001; Donaldson et al., 2005). Purification of midbrain dopamine
neurons derived from pluripotent stem cells has proven more
challenging than enrichment from primary tissue. Specifically,
stem cell-derived cultures are rarely synchronized temporally or
spatially and will therefore simultaneously contain cells of diverse
developmental stages and cell fates. Thus, if a marker is expressed
in several different cell types during development it will not be
particularly suitable for sorting. TH for example, which labels
catecholaminergic neurons, including midbrain dopamine neu-
rons, is transiently expressed in multiple lineages during devel-
opment, including cells with proliferative capacity (Lindeberg
et al., 2004). Therefore, when the TH promoter was used to drive
GFP expression in stem cell-derived midbrain cultures, dopamine
neurons were labeled, as well as proliferating cells. To acquire
an enriched neuronal culture it was necessary to combine the
TH-GFP reporter with a negative selection step for SSEA-1 to
remove proliferating GFP+ cells (Hedlund et al., 2007). Pitx3 is a
more restrictedmarker for midbrain dopamine neurons than TH.
While Pitx3 is transiently expressed in skeletal muscle and the lens
of the eye (Smidt et al., 2004; Zhao et al., 2004), those cell types are
typically not generated during in vitro differentiation of stem cells
toward a midbrain fate (Hedlund et al., 2008). Transplantation of
FACS-enriched Pitx3-eGFP ESC-derived dopamine neurons into
Parkinsonian rats, reversed drug-induced rotational behavior and
the transplanted neurons innervated the host striatum (Hedlund
et al., 2008; Ganat et al., 2012).
However, FACS-enriched cell suspensions, containing ≥80%
Pitx3-GFP+ neurons, infrequently gave rise to tumors due to
the presence of SSEA-1+ proliferative cells. If the cells were
subjected to a second round of FACS, up to 98% dopamine
neurons were retrieved, and these cells survived in vitro when
plated on astrocytes (Hedlund et al., 2008) or matri gel (Ganat
et al., 2012). These dopamine neurons also survived in vivo
and reversed amphetamine-induced rotational behavior without
forming tumors. However, the survival of the cells was affected,
either from mechanical injury caused by the second sorting step
or through the exclusion of cell types that provided trophic sup-
port (Ganat et al., 2012). To discriminate between these two
options, double-sorted neurons should be transplanted alone
or in combination with the negative fraction that was removed
between the first and second FACS.
Sorting and transplanting mature dopamine neurons derived
from pluripotent stem cells is clearly feasible, but the efficiency
is relatively low. FACS and transplantation of dopamine neu-
rons at the stage of cell cycle exit, using a Nurr1-GFP reporter,
resulted in more robusts grafts than a Pitx3-GFP reporter. While
neuronal progenitor selection using a Hes5-GFP reporter line,
resulted in grafts that contained amajority of non-dopamine neu-
rons (Ganat et al., 2012). This indicates the timing of selection
and transplantation is of importance and that very early markers
might be less beneficial than later ones. The floor plate marker
Corin has been used to isolate ventral midline cells, from the
developing midbrain, which co-expressed the dopamine neuron
marker Lmx1a (Ono et al., 2007). However, the broad anterior-
posterior expression domain of Corin makes it less suitable for
selecting midbrain progenitors from pluripotent stem cells that
are difficult to restrict spatially.
Importantly, it is the SNc (A9) dopamine neurons that inner-
vate the dorsolateral striatum after transplantation in Parkinson
disease models and induce functional recovery. VTA (A10)
dopamine neurons mainly appear to project to the frontal cortex
and other forebrain areas (Thompson et al., 2005; Grealish et al.,
2010). Thus, it is not sufficient to enrich for dopamine neurons,
but specific cell-surface markers or genetic labeling to distinguish
SNc and VTA are needed. In this regard, the expression of the
G-protein inward rectifying potassium channel subunit 2 (Girk2,
Kir3.2) was previously considered a specific marker of vulner-
able SNc dopamine neurons (Mendez et al., 2005; Thompson
et al., 2005; Lammel et al., 2008). However, a detailed study of
the human midbrain revealed that Girk2 expression levels were
similar in the ventral and dorsal tiers of the human SNc (Reyes
et al., 2012), with 77% of SNc and 55% of VTA neurons showing
a strong Girk2 immunoreactivity. The proportion of TH neu-
rons showing colocalization with Girk2 was similar in the mouse
brain (Fu et al., 2012; Reyes et al., 2012). Therefore, the most
reliable criterion to separate SNc and VTA dopamine neurons in
vitro appears to instead be the absence of calbindin-D28k in SNc
dopamine neurons (German et al., 1992; Damier et al., 1999a).
Nonetheless, it should be noted that around 12% of human and
20% of mouse pars medialis SNc dopamine neurons co-express
calbindin-D28k (Reyes et al., 2012).
Motor neurons can be purified using MACS and FACS.
p75NTR has been used to isolate motor neurons from the
www.frontiersin.org May 2014 | Volume 8 | Article 109 | 9
Allodi and Hedlund In vitro neurogenesis from stem cells
developing spinal cord using immunopanning (Camu and
Henderson, 1992; Wiese et al., 2010) or MACS (Arce et al., 1999).
FF, FR, and S motor neuron populations have been isolated (for
gene expression profiling without further culturing) by FACS
following injection of retrograde tracers into muscle (Saxena
et al., 2009). Corticospinal motor neurons have also been puri-
fied using FACS, based on dye injections in utero (Arlotta et al.,
2005; Ozdinler and Macklis, 2006). mESC-derived motor neu-
rons can be enriched by FACS using the Hb9 promoter to drive
eGFP expression (Wichterle et al., 2002) (Figure 6). This selection
approach has also been successfully applied to humanmotor neu-
rons derived from ESCs (Di Giorgio et al., 2008; Marchetto et al.,
2008) and from induced pluripotent stem cells (Corti et al., 2012).
Hb9 shows a high specificity for motor neurons in the nervous
system, although there are smaller populations of Hb9+ interneu-
rons, as shown both in Drosophila (Odden et al., 2002) and
mouse (Wilson et al., 2005). Hb9 is also expressed outside the ner-
vous system, including the pancreas, but no non-neuronal Hb9+
cells appear to be generated during differentiation of pluripo-
tent stem cells into motor neurons using RA and Shh. Genetic
labeling could allow for isolation specifically of trunc- (MMC)
or limb-innervating (LMC) motor neurons based on Lhx3 or
FoxP1 expression, respectively, in combination with a Hb9-GFP
reporter. As Lhx3 is broadly expressed in motor neurons during
early development, the presence or lack of FoxP1 would be a the
more reliable discriminatory marker.
Motor neurons, isolated by FACS using the Hb9-GFP reporter
survive in vitrowhen supplemented with a combination of growth
factors, including GDNF, BDNF, CNTF, and NT3 (Wichterle
et al., 2002). Hb9+ motor neurons also survive in vivo after
grafting and connect with target muscles (Wichterle et al.,
2002; Harper et al., 2004; Gao et al., 2005; Deshpande et al.,
2006; Bryson et al., 2014), and induce functional recovery in
motor neuron lesion models (Deshpande et al., 2006). However,
published studies up to date have transplanted unsorted ESC-
derived motor neurons. FACS-purified motor neurons will pre-
sumably show lower survival rate in vivo, but that remains to
FIGURE 6 | Motor neurons can be purified by FACS using Hb9-GFP
expression. Spinal motor neurons derived from Hb9-GFP mESCs extend
processes and express Islet-1/2. Hoechst staining of all nuclei shows that
the intact culture contains cells other than motor neurons (A). Hb9-GFP
motor neurons enriched by FACS show a healthy appearance with extended
processes 1 day post sorting (B).
be investigated. Recent experiments showed that both astro-
cytes and muscle secrete factors that promote survival of motor
neurons in vitro. However, astrocyte-conditioned media saved
substantially more motor neurons than muscle-conditioned
media and only astrocyte-secreted factors could rescue motor
neurons after unilateral limb bud removal (Taylor et al., 2007).
These data indicate that co-transplantation of purified motor
neurons with astrocytes could be beneficial for graft survival.
Alternatively, stem cells can be genetically engineered to over
express growth factors to trophically support generated MNs
(Bryson et al., 2014).
Furthermore, pan-neuronal sorting strategies have utilized
the cell surface expression of PSA-NCAM to enrich for neu-
rons (Schmandt et al., 2005; Panman et al., 2011). As astrocytes
can express PSA-NCAM (Minana et al., 1998) this approach
could enrich for a mixture of neurons and glia. PSA-NCAM is
also expressed on other non-neuronal cells, including beta cells
(Kiss et al., 1994; Bernard-Kargar et al., 2001). However, it is
unlikely that pancreatic cells, formed from definite endoderm
(D’Amour et al., 2005) are generated by the conditions used to
derive midbrain and spinal neurons.
Ideally specific neuronal populations can in the future be
isolated using a combination of two to three cell surface mark-
ers, which would bypass the need for viral vectors or genetic
engineering of stem cells for labeling.
STRUCTURED HETEROGENEITY TO STUDY DEVELOPMENT
AND DISEASE IN A DISH
Modeling development, disease and prospective therapies in a
dish could benefit enormously from systems displaying structured
heterogeneity, where desired neurons are appropriately connected
pre-and post-synaptically. Ideally, in vitro systems should be com-
plex enough to reflect vital processes of development and disease,
yet simple enough to be reproducible, and therefore likely would
benefit from some reductionism. By modulating the extrin-
sic environment, and thus intrinsic determinants, it should be
possible to accomplish directed sequential generation of neural
progenitors within a domain, followed by self-organization and
synaptic establishment to create a reductionist model of that brain
region.
Importantly, mouse and human pluripotent stem cells
have been successfully used to generate self-organizing three-
dimensional structures that resemble the cortex (Eiraku et al.,
2008; Gaspard et al., 2008; Lancaster et al., 2013). These
“organoids” could be used both to study human brain develop-
ment and disease, as exemplified by modeling of microcephaly
using iPSCs (Lancaster et al., 2013). Other highly complex sys-
tems, such as the optic cup structure has also been formed
through self-organization in human ESC culture, with the retina
growing into amultilayered tissue containing both rods and cones
(Nakano et al., 2012). This studies point out the remarkable possi-
bility to reconstruct development and generate specific structures
in vitro from pluripotent stem cells.
While no studies so far have generated a three dimen-
sional midbrain structure in vitro, the existing induction pro-
tocols generate several neuronal types that are present in the
midbrain/hindbrain, including dopamine neurons, oculomotor
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FIGURE 7 | Proliferative cells can become the main component of
differentiated stem cell cultures with time. Differentiation of pluripotent
stem cells using RA and Shh results in the generation of motor neurons
(15–30%) and interneurons, particularly V0 and V1. The culture will also
contain neuronal progenitors and pluripotent stem cells (top panel). If the
intact culture is maintained, after differentiation, proliferating cells will soon
become the main component (top panel). Enrichment of motor neurons,
using FACS for the Hb9-GFP reporter, results in cultures mainly composed of
motor neurons, enabling an analysis of motor neuron specific properties and
functions (bottom panel). However, with time, if cultures are not mitotically
inhibited, sorted cultures will contain an increasing number of proliferating
cells, since FACS rarely results in 100% enrichment (bottom panel).
neurons (Figures 4B,C) and serotonin neurons (Lee et al., 2000;
Kim et al., 2002). Interestingly, transplantation experiments using
primate ESC-derived neurons differentiated toward a midbrain
fate revealed that ESC-derived dopamine neurons appropriately
innervated ESC-derived striatal neurons (DARPP32+ and Bf-1+)
within the graft (Ferrari et al., 2006) (Figure 8A). The target
innervation was specific as other neurons within the graft, includ-
ing Nkx2.1+ ganglionic eminence neurons, Nkx2.2+ pallidal
and diencephalic progenitors or Pax6+ dorsal telencephalic pro-
genitors did not appear innervated (Ferrari et al., 2006). This
clearly shows that despite the diverse cellular composition of
the graft, ESC-derived dopamine neurons displayed an appro-
priate target connectivity and functionality. It also shows that
an induction protocol used to generate dopamine neurons can
generate their striatal target neurons. While this could be a dis-
advantage in transplantation experiments, where grafted neurons
mainly innervate targets within the graft rather than the host, it is
advantageous for in vitro experimentation where a self-organizing
circuitry could be generated within a dish. Further experimen-
tation is required to determine if a complete circuitry, including
GABAergic globus pallidus neurons (Figure 8A) are also gener-
ated in the Shh, Fgf8 and Wnt-based induction protocols or if
modulations are needed to accomplish this.
Generating a circuitry for motor neurons based on ESC-
derived cells is naturally more complex since motor neurons
synapse onto muscle outside the CNS. Here, it will likely be nec-
essary to generate muscle and motor neurons separately, since the
induction protocols are quite distinct. Commonly, the inductive
spinal motor neuron protocols (and midbrain neuron protocols
as well) utilize an initial step called embryoid body (EB) for-
mation, where floating spheres are generated, which can form
all three germ layers. Here, a neuroectoderm fate is enforced,
at the expense of mesoderm and endoderm formation, with the
imposed action of RA and Shh to drive the generation of neurons.
As discussed above, these inductive protocols do not only gen-
erate spinal motor neurons, but also other cell types, including
several distinct interneuron populations, that are born in the
intersection of these two morphogens (Wichterle et al., 2002)
(Figure 7). With time, glia progenitors also appear and mature
into astrocytes. Thus, this EB based differentiation, mimics nor-
mal neural development and in sorts generates a “mini” spinal
cord containing all the appropriate cell types. The main thing this
system is lacking, is an appropriate connection to the periphery.
If these EBs are attached, the motor neurons generated within,
extend long distally projecting axons. When the generated motor
neurons are plated directly onto muscle, they form appropri-
ate connections with their targets through NMJs (Corti et al.,
2012). However, to ensure that motor neurons and muscle are
appropriately connected, it will be beneficial to use microfluidics
devices where motor neurons and muscle cell bodies are kept sep-
arate and motor axons can connect to muscle through narrow
channels. Thus, the only connection is through the motor axon
and the muscle. Here the flow can be directed so that factors
secreted by either compartment can have more or less influence
on the other compartment (Figure 8B). While partly dissoci-
ated EBs could be fitted into such microfluidics devices, it could
be beneficial to isolate motor neurons by FACS (Figure 6) or
MACS using transgenic expression of Hb9-GFP or cell surface
expression of p75NTR (Figure 8B). This would likely ensure that
motor neurons perform less targeting within the EB and instead
grow to the distal muscle target. Skeletal muscle has been suc-
cessfully generated from human ESCs and iPSCs (Barberi et al.,
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FIGURE 8 | Pluripotent stem cells could be utilized to generate a
self-organizing midbrain circuitry or structured connectivity
between motor neurons and muscle. (A) Utilizing the morphogens
Shh, Fgf8, and Wnt1, pluripotent stem cells generate dopamine
neurons, striatal neurons, and GABAergic neurons that could form a
self-organizing circuitry during appropriate conditions. Remaining
pluripotent stem cells could be removed by FACS for SSEA.
Astrocytes, generated from stem cells through the action of RA,
Shh, and FGF1/2 could be added to the culture to promote
synaptogenesis. (B) Motor neurons can be generated from pluripotent
stem cells by the addition of RA and Shh and further enriched
through FACS for Hb9-GFP or the cell surface marker p75NTR. These
motor neurons can be appropriately connected to muscle, derived
from stem cells through e.g., low-density culture, enrichment for
CD73+NCAM+ myogenic progenitors and subsequent differentiation in
N2 media. Culturing in a microfluidics chamber ensures that
connectivity is appropriately achieved and that flow between the
compartments can be regulated.
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2007; Darby et al., 2012; Hosoyama et al., 2014). The induction
protocols used include; using low density cell culture and selec-
tion for CD73+ myogenic cells based on NCAM+ cell surface
expression and further differentiation (Figure 8B) (Barberi et al.,
2007); conditional expression of Pax7 to derive myogenic pro-
genitors (Darby et al., 2012) and a sphere-based culture system
where FGF2-conditioned expansion induced myogenic progeni-
tor generation (Hosoyama et al., 2014). Such a NMJ system will
be highly beneficial for studying effects on axonal transport, both
retrograde and anterograde. If muscle or motor neurons were
derived from iPSCs from ALS patients, it could enable an anal-
ysis of how one cell with disease affects a healthy counterpart.
Here, we could also study the role of interneurons in disease
pathogenesis in ALS, by adding disease-interneurons to a healthy
motor neuron-muscle circuitry or vice versa. Spinal interneu-
rons are, as previously mentioned, generated simultaneously with
motor neurons when pluripotent stem cells are exposed to Shh
and RA. These interneurons, derived from healthy individuals or
motor neuron disease patients, could be enriched for by remov-
ing remaining pluripotent stem cells (SSEA+) andmotor neurons
(p75NTR+). Any glial progenitors present would be in a clear
minority and could be mitotically inhibited by the addition of
e.g., AraC. Furthermore, to better understand neuronal vulner-
ability and protection in Parkinson disease and ALS, which are
axonopathies, it would be very valuable to study the connectivity
with the target cells. Hence, in vitromodeling of Parkinson disease
could benefit from keeping dopamine neurons and their striatal
targets in separate compartments, through microfluidics devices,
to better visualize early axonal dysfunction. Here, dopamine neu-
rons, could be enriched by FACS using a Nurr1-GFP or Pitx3-GFP
reporter (Hedlund et al., 2008; Ganat et al., 2012) and cultured in
one compartment, while their dorsolateral striatal targets, could
be enriched for by e.g., Dopamine D1 receptor, Drd1a, expression
(Gerfen et al., 1990; Lobo et al., 2006; Ena et al., 2013) and grown
in the other compartment. For in vitro drug screening purposes,
being able to quantify loss of connectivity, for example of the
NMJ or dopamine neuron-striatum, rather than analyzing neu-
ronal loss would improve the understanding of the mechanisms
of action of particular drugs and their usability in vivo.
In summary, specific neuronal fates are determined through
the interplay between extrinsic morphogen signals and intrinsic
determinants. These processes can be recapitulated when direct-
ing neurogenesis from pluripotent stem cells in a dish. Utilizing
morphogen signals to derive neurons from stem cells in vitro,
e.g., Shh and Fgf8 to generate dopamine neurons or Shh and
RA for motor neuron induction, will lead to the generation of a
repertoire of cell types, which are normally generated at the inter-
section of the used signals. If morphogen signals are combined
with forced expression of transcription factors that are lineage
determinants, specific neuron types can be highly enriched for.
A similar end result can be achieved using FACS or MACS to
enrich for the desired neuronal types. Here, cell specific surface
markers are required or genetic engineering to label only the
desired cells for the selection procedure. However, acquiring cul-
tures containing one cell type only typically necessitate a negative
selection step, to remove cells with proliferative capacity, or treat-
ment with agents inhibiting mitosis. If neurons are to be used for
cellular therapies, it is vital to utilize cultures containing only the
desired cell type(s), for functionality, efficacy and safety reasons.
It could also be advantageous in the study of cell intrinsic prop-
erties and in drug screens. However, in vitro systems displaying
structured heterogeneity, where neurons are appropriately con-
nected, pre- and post-synaptically, representing a reductionist
model of that brain region, could be superior for studying devel-
opment and disease in a dish. Such systems can sometimes be
acquired through exposing pluripotent stem cells to morphogenic
signals followed by self-organization in vitro. It should also be
possible to construct simplified circuitry systems by artificially
combining selected cell types, such as motor neurons and muscle
that are generated in distinct induction protocols.
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